Back to search

Article

In Silico RNA-Seq Analysis Reveals Key Transcriptomic Signatures in Pancreatic Cancer

2025-05-07

Abstract excerpt

<title>Abstract</title> <p>Pancreatic cancer is one of the most lethal malignancies, with limited therapeutic options and a five-year survival rate below 10%. This study aimed to elucidate the molecular mechanisms underlying pancreatic cancer progression and identify potential biomarkers and therapeutic targets through in silico analysis of RNA sequencing (RNA-Seq) data. Using the publicly available GSE119224 dat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2e9f8f6c-95c4-567d-9483-daa16c9b49a8
DOI
10.21203/rs.3.rs-6588745/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
In Silico RNA-Seq Analysis Reveals Key Transcriptomic Signatures in Pancreatic CancerDOI 10.21203/rs.3.rs-6588745/v1
RNA sequencing analyses reveal novel differentially expressed genes and pathways in pancreatic cancerSemantic proximity
Analysis of a large cohort of pancreatic cancer transcriptomic profiles to reveal the strongest prognostic factorsSemantic proximity
Screening and identification of potential biomarkers for pancreatic cancer: An integrated bioinformatics analysisSemantic proximity
Network‐based integration of mRNA and miRNA profiles reveals new target genes involved in pancreatic cancerSemantic proximity
Expression profiles analysis of pancreatic cancer.Semantic proximity
An integrative mutational and network analysis of pancreatic cancer reveals key genes, and signalling pathways.Semantic proximity
Identification of Blood-based Non-invasive Biomarkers and Therapeutic Agents against Pancreatic Ductal Adenocarcinoma (PDAC): A Network-based StudySemantic proximity
A transcriptomics-based meta-analysis combined with machine learning approach identifies a secretory biomarker panel for diagnosis of pancreatic adenocarcinomaSemantic proximity
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.Semantic proximity
Pancreatic Cancer DatabaseSemantic proximity
Identification of new biomarkers for pancreatic cancer management: A bioinformatics analysisSemantic proximity
Integrated Bioinformatics Analysis of Gene Expression Profiles for Potential Biomarker Identification Towards Early Therapeutic Intervention in Pancreatitis and Pancreatic ductal adenocarcinomaSemantic proximity
Select a neighboring publication to make it the new centre.